NMO	neuromyelitis optica
NMOSD	neuromyelitis optica spectrum disorders
CNS	central nervous system
HSCT	hematopoietic stem cell transplantation
AQP4	aquaporin-4
CSF	cerebrospinal fluid
MOG-Ab	myelin oligodendrocyte glycoprotein antibody
BBB	the blood–brain barrier
GM-CSF	granulocyte-macrophage colony-stimulating factor
LETM	longitudinally extensive transverse myelitis
MRI	magnetic resonance imaging
AZA	azathioprine
MMF	mycophenolate mofetil
RTX	rituximab
FDA	Food and Drug Administration
EMA	European Medicine Agency
HR	hazard ratio
AuHSCT	autologous HSCT
AlHSCT	allogeneic HSCT
HSCs	hematopoietic stem cells
GVHD	graft versus host disease
TRM	transplant-related mortality
EAE	experimental autoimmune encephalomyelitis
TBI	total body irradiation
Cy	cyclophosphamide
MS	multiple sclerosis
ATG	antithymocyte globulin
EDSS	Expanded Disability Status Scale
OSMS	opticospinal multiple sclerosis
EBMT	European Group for Blood and Marrow Transplantation
AID	autoimmune diseases
HLA	human leukocyte antigen
MFD	matched family donor
MUD	matched unrelated donors
Flu	fludarabine
Threo	threosulfan
VOD	veno-occlusive-disease